Lorente J A, Landín L, De Pablo R, Renes E, Rodríguez-Díaz R, Liste D
Unidad de Cuidados Intensivos, Hospital Ramón y Cajal, Madrid, Spain.
Crit Care Med. 1993 Sep;21(9):1312-8. doi: 10.1097/00003246-199309000-00013.
To investigate whether increasing oxygen delivery (DO2) by increasing hematocrit results in increases in oxygen uptake (VO2) in septic patients with an abnormal DO2/VO2 relationship.
Prospective, randomized, interventional crossover study.
Tertiary care hospital.
A consecutive sample of 16 patients admitted to the intensive care unit, who were diagnosed as having severe sepsis by defined criteria and who had a hemoglobin concentration of < 10 g/dL.
Patients received, in random order, an infusion of dobutamine (10 micrograms/kg/min) and a blood transfusion (800 mL of packed red blood cells in 90 mins). Hemodynamic and oxygen transport variables were determined before and after each treatment, allowing at least 20 mins during the infusion of dobutamine to achieve the steady state.
Changes in DO2 and VO2 induced by each intervention were measured. Dobutamine significantly increased DO2 (48.5 +/- 6.9%; p = .0001) and VO2 (21.7 +/- 3.3%; p = .0001). Blood transfusion increased DO2 (21.4 +/- 4.3%; p = .005) but VO2 did not change significantly (2.2 +/- 4.1%). Correlation coefficients for the percent changes of DO2 and VO2 (r2 = .67, p = .001 for dobutamine; and r2 = 21, p = .07 for blood transfusion) were significantly different for each treatment (p = .0001).
In patients with an abnormal DO2-dependent VO2, as shown by increases in VO2 brought about by an infusion of dobutamine, blood transfusion does not significantly increase VO2, despite significant changes in DO2. The VO2, in some critically ill patients, depends more on blood flow than on global DO2.
探讨在氧输送(DO2)/氧摄取(VO2)关系异常的脓毒症患者中,通过提高血细胞比容来增加氧输送是否会导致氧摄取增加。
前瞻性、随机、干预性交叉研究。
三级护理医院。
连续选取16例入住重症监护病房的患者,这些患者根据既定标准被诊断为严重脓毒症,且血红蛋白浓度<10 g/dL。
患者随机接受多巴酚丁胺输注(10微克/千克/分钟)和输血(90分钟内输注800毫升浓缩红细胞)。在每次治疗前后测定血流动力学和氧输送变量,多巴酚丁胺输注期间至少留出20分钟以达到稳态。
测量每次干预引起的DO2和VO2变化。多巴酚丁胺显著增加DO2(48.5±6.9%;p = 0.0001)和VO2(21.7±3.3%;p = 0.0001)。输血增加了DO2(21.4±4.3%;p = 0.005),但VO2没有显著变化(2.2±4.1%)。每次治疗中DO2和VO2变化百分比的相关系数(多巴酚丁胺:r2 = 0.67,p = 0.001;输血:r2 = 0.21,p = 0.07)差异有统计学意义(p = 0.0001)。
在因输注多巴酚丁胺导致VO2增加而表现出DO2依赖性VO2异常的患者中,尽管DO2有显著变化,但输血并未显著增加VO2。在一些危重症患者中,VO2更多地取决于血流而非整体DO2。